Elena Crestani1, Hani Harb1, Louis-Marie Charbonnier1, Jonathan Leirer2, Alison Motsinger-Reif3, Rima Rachid1, Wanda Phipatanakul1, Rima Kaddurah-Daouk4, Talal A Chatila5. 1. Division of Immunology, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, Mass. 2. Bioinformatics Research Center, Department of Statistics, North Carolina State University, Raleigh, NC. 3. Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, Durham, NC. 4. Department of Psychiatry and Behavioral Sciences and the Duke Institute for Brain Sciences, Duke University, Durham, NC. 5. Division of Immunology, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, Mass. Electronic address: talal.chatila@childrens.harvard.edu.
Abstract
BACKGROUND: Food allergy (FA) affects an increasing proportion of children for reasons that remain obscure. Novel disease biomarkers and curative treatment options are strongly needed. OBJECTIVE: We sought to apply untargeted metabolomic profiling to identify pathogenic mechanisms and candidate disease biomarkers in patients with FA. METHODS: Mass spectrometry-based untargeted metabolomic profiling was performed on serum samples of children with either FA alone, asthma alone, or both FA and asthma, as well as healthy pediatric control subjects. RESULTS: In this pilot study patients with FA exhibited a disease-specific metabolomic signature compared with both control subjects and asthmatic patients. In particular, FA was uniquely associated with a marked decrease in sphingolipid levels, as well as levels of a number of other lipid metabolites, in the face of normal frequencies of circulating natural killer T cells. Specific comparison of patients with FA and asthmatic patients revealed differences in the microbiota-sensitive aromatic amino acid and secondary bile acid metabolism. Children with both FA and asthma exhibited a metabolomic profile that aligned with that of FA alone but not asthma. Among children with FA, the history of severe systemic reactions and the presence of multiple FAs were associated with changes in levels of tryptophan metabolites, eicosanoids, plasmalogens, and fatty acids. CONCLUSIONS: Children with FA have a disease-specific metabolomic profile that is informative of disease mechanisms and severity and that dominates in the presence of asthma. Lower levels of sphingolipids and ceramides and other metabolomic alterations observed in children with FA might reflect the interplay between an altered microbiota and immune cell subsets in the gut.
BACKGROUND:Food allergy (FA) affects an increasing proportion of children for reasons that remain obscure. Novel disease biomarkers and curative treatment options are strongly needed. OBJECTIVE: We sought to apply untargeted metabolomic profiling to identify pathogenic mechanisms and candidate disease biomarkers in patients with FA. METHODS: Mass spectrometry-based untargeted metabolomic profiling was performed on serum samples of children with either FA alone, asthma alone, or both FA and asthma, as well as healthy pediatric control subjects. RESULTS: In this pilot study patients with FA exhibited a disease-specific metabolomic signature compared with both control subjects and asthmatic patients. In particular, FA was uniquely associated with a marked decrease in sphingolipid levels, as well as levels of a number of other lipid metabolites, in the face of normal frequencies of circulating natural killer T cells. Specific comparison of patients with FA and asthmatic patients revealed differences in the microbiota-sensitive aromatic amino acid and secondary bile acid metabolism. Children with both FA and asthma exhibited a metabolomic profile that aligned with that of FA alone but not asthma. Among children with FA, the history of severe systemic reactions and the presence of multiple FAs were associated with changes in levels of tryptophan metabolites, eicosanoids, plasmalogens, and fatty acids. CONCLUSIONS:Children with FA have a disease-specific metabolomic profile that is informative of disease mechanisms and severity and that dominates in the presence of asthma. Lower levels of sphingolipids and ceramides and other metabolomic alterations observed in children with FA might reflect the interplay between an altered microbiota and immune cell subsets in the gut.
Authors: L Antunes; A P Duarte de Souza; P D de Araújo; L A Pinto; M H Jones; R T Stein; P M Pitrez Journal: Allergol Immunopathol (Madr) Date: 2017-12-24 Impact factor: 1.667
Authors: Erik J Saude; Christopher D Skappak; Shana Regush; Kim Cook; Amos Ben-Zvi; Allan Becker; Redwan Moqbel; Brian D Sykes; Brian H Rowe; Darryl J Adamko Journal: J Allergy Clin Immunol Date: 2011-03 Impact factor: 10.793
Authors: A Cianferoni; R Saltzman; F Saretta; S Barni; E Dudek; M Kelleher; J M Spergel Journal: Clin Exp Allergy Date: 2017-08-23 Impact factor: 5.018
Authors: Marie-Claire Arrieta; Andrea Arévalo; Leah Stiemsma; Pedro Dimitriu; Martha E Chico; Sofia Loor; Maritza Vaca; Rozlyn C T Boutin; Evan Morien; Mingliang Jin; Stuart E Turvey; Jens Walter; Laura Wegener Parfrey; Philip J Cooper; Brett Finlay Journal: J Allergy Clin Immunol Date: 2017-12-11 Impact factor: 10.793
Authors: Ying Liu; Jing Zheng; Hong Ping Zhang; Xin Zhang; Lei Wang; Lisa Wood; Gang Wang Journal: Allergy Asthma Immunol Res Date: 2018-11 Impact factor: 5.764
Authors: Anne M Evans; Claire O'Donovan; Mary Playdon; Chris Beecher; Richard D Beger; John A Bowden; David Broadhurst; Clary B Clish; Surendra Dasari; Warwick B Dunn; Julian L Griffin; Thomas Hartung; Ping- Ching Hsu; Tao Huan; Judith Jans; Christina M Jones; Maureen Kachman; Andre Kleensang; Matthew R Lewis; María Eugenia Monge; Jonathan D Mosley; Eric Taylor; Fariba Tayyari; Georgios Theodoridis; Federico Torta; Baljit K Ubhi; Dajana Vuckovic Journal: Metabolomics Date: 2020-10-12 Impact factor: 4.290